Pila Pharma
Malm├╢
About Pila Pharma
Pila Pharma is a clinical stage biotech company developing a potent, selective TRPV1 antagonist, XEN-D0501, as treatment of type 2 diabetes, obesity, and the rare painful disease erythromelalgia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $11.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: sto:PILA
- Website: pilapharma.com
- Phone: +4528606383
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/pila-pharma-51465 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.